Targeted genetic dependency screen is an efficient approach to identify somatic cancer alterations and was used to identify gain-of-function (GOF) mutations in lung cancer for FGFR4, MAP3K9, and PAK5 kinases [119]. The gene discussed is FGFR4; the disease is lung carcinoma.